Nine batches of drugs produced by nine enterprises such as Shenzhen Hanyu Pharmaceutical Co., Ltd. were found to be unqualified after inspection by nine drug inspection institutions such as CFDA. So do you know the list of these drugs? Follow the editor to have a look. If you have any at home, you must throw them away quickly!
The manufacturer, drug product name and production batch number of the unqualified products are as follows:
The batch number of somatostatin for injection produced by Shenzhen Hanyu Pharmaceutical Co., Ltd. is 1123161204;
The batch number of Anwei tablets produced by Changchun People's Pharmaceutical Group Co., Ltd. is 20160701;
The batch number of gansuikang capsule produced by Harbin Dayang Pharmaceutical Co., Ltd. is 151202;
The batch number of Jiangzhining granules produced by Changchun yinnock Pharmaceutical Co., Ltd. is 20160902;
Beijing Tongrentang science and Technology Development Co., Ltd. pharmaceutical factory produces 15080858 Kaixiong SHUNQI pills;
Chongqing Lingfang Sanfan biopharmaceutical Co., Ltd. produces a lot number of 150903 musk bone strengthening paste;
The batch number of pepsin granules produced by Taikang Haien Pharmaceutical Co., Ltd. is 161101;
Duoduo Pharmaceutical Co., Ltd. produces vitamin E nicotinate capsules with batch number of 1609231;
The batch number of cefradine for injection produced by Qilu Pharmaceutical Co., Ltd. is 5120108ae.
Unqualified items include character, content determination, disintegration time limit, weight difference, loading difference, paste content and potency determination For the above-mentioned unqualified drugs, the relevant provincial food and drug supervision and administration departments have taken control measures such as sealing up and detaining, requiring the enterprises to suspend the sale and use of the products, recall the products, and carry out rectification.
I. The marked manufacturers, product names and batch numbers of unqualified products are: somatostatin for injection produced by Shenzhen Hanyu Pharmaceutical Co., Ltd. with batch number of 1123161204, Anwei tablet produced by Changchun People's Pharmaceutical Group Co., Ltd. with batch number of 20160701, Gansukang capsule produced by Harbin Dayang Pharmaceutical Co., Ltd. with batch number of 151202, vinorelbine Jiangzhining granules with batch number of 20160902 produced by Industrial Co., Ltd., Kaixiong SHUNQI pills with batch number of 15080858 produced by pharmaceutical factory of Beijing Tongrentang science and Technology Development Co., Ltd., musk Zhuanggu paste with batch number of 150903 produced by Chongqing Lingfang Sanfan biopharmaceutical Co., Ltd., pepsin granules with batch number of 161101 produced by Taikang Haien Pharmaceutical Co., Ltd., Duoduo Pharmaceutical Co., Ltd The batch number of vitamin E nicotinic acid ester capsule produced by the company is 1609231, and that of cefradine for injection produced by Qilu Pharmaceutical Co., Ltd. is 5120108ae. Unqualified items include character, content determination, disintegration time limit, weight difference, loading difference, paste content and potency determination.
II. For the above-mentioned unqualified drugs, the relevant provincial food and drug administration has taken control measures such as sealing up and detaining, requiring the enterprises to suspend the sale and use of the products, recall the products, and make rectification.
3. The State Food and drug administration requires the provincial food and drug administration where the relevant units are located to investigate the illegal activities of the above-mentioned enterprises in accordance with the provisions of Article 73, 74 and 75 of the drug administration law of the people's Republic of China. Within three months, the State Food and drug administration will publicly investigate the enterprises or enterprises that produce and sell unqualified drugs The handling results and relevant information of the unit shall be reported to the General Administration in a timely manner.